Literature DB >> 6416395

Alzheimer's disease: recent advances and future prospects.

J F Deakin.   

Abstract

Entities:  

Mesh:

Year:  1983        PMID: 6416395      PMCID: PMC1549534          DOI: 10.1136/bmj.287.6402.1323

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  16 in total

1.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

Review 2.  Alzheimer's disease: a disorder of cortical cholinergic innervation.

Authors:  J T Coyle; D L Price; M R DeLong
Journal:  Science       Date:  1983-03-11       Impact factor: 47.728

3.  Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease.

Authors:  A J Cross; T J Crow; E K Perry; R H Perry; G Blessed; B E Tomlinson
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-10

4.  Reduced choline-acetyltransferase activity in scrapie mouse brain.

Authors:  J R McDermott; H Fraser; A G Dickinson
Journal:  Lancet       Date:  1978-08-05       Impact factor: 79.321

5.  Distribution of Alzheimer's neurofibrillary changes in the brain stem and hypothalamus of senile dementia.

Authors:  T Ishii
Journal:  Acta Neuropathol       Date:  1966-03-04       Impact factor: 17.088

6.  Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies.

Authors:  D M Bowen; C B Smith; P White; A N Davison
Journal:  Brain       Date:  1976-09       Impact factor: 13.501

7.  Serotonin concentrations in brain and blood of scrapie-infected and normal hamsters and mice.

Authors:  R G Rohwer; L M Neckers; J B Trepel; D C Gajdusek; R J Wyatt
Journal:  Brain Res       Date:  1981-09-14       Impact factor: 3.252

8.  Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

Authors:  E K Perry; B E Tomlinson; G Blessed; K Bergmann; P H Gibson; R H Perry
Journal:  Br Med J       Date:  1978-11-25

9.  Changes in brain cholinesterases in senile dementia of Alzheimer type.

Authors:  E K Perry; R H Perry; G Blessed; B E Tomlinson
Journal:  Neuropathol Appl Neurobiol       Date:  1978 Jul-Aug       Impact factor: 8.090

10.  Physostigmine and arecoline: effects of intravenous infusions in Alzheimer presenile dementia.

Authors:  J E Christie; A Shering; J Ferguson; A I Glen
Journal:  Br J Psychiatry       Date:  1981-01       Impact factor: 9.319

View more
  2 in total

1.  Increased GFAp levels in CSF as a marker of organicity in patients with Alzheimer's disease and other types of irreversible chronic organic brain syndrome.

Authors:  R Crols; J Saerens; M Noppe; A Lowenthal
Journal:  J Neurol       Date:  1986-06       Impact factor: 4.849

Review 2.  Pathogenesis of Alzheimer's disease--beyond the cholinergic hypothesis: discussion paper.

Authors:  P J Harrison
Journal:  J R Soc Med       Date:  1986-06       Impact factor: 5.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.